FIELD: medicine, otorhinolaryngology. SUBSTANCE: zinnate is additionally introduced at the quantity of 125-250 mg to take in twice a day for 5-7 days perorally at the background of laser and irrigation therapies, moreover, for irrigation therapy 2%-solution of ascorbic acid is applied, and at conducting laser therapy an additional impact upon submaxillary area is performed. EFFECT: higher efficiency of therapy. 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF PATIENTS WITH CHRONIC TONSILLITIS | 2000 |
|
RU2163130C1 |
| METHOD FOR TREATMENT OF CHRONIC TONSILLITIS | 2003 |
|
RU2240132C1 |
| METHOD FOR TREATING HYPERTROPHIC FAUCIAL TONSILS | 1992 |
|
RU2069984C1 |
| METHOD FOR TREATING THE CASES OF TONSILLITIS AGGRAVATED WITH LYMPHADENITIS | 1998 |
|
RU2128995C1 |
| METHOD FOR TREATING INFLAMMATORY DISEASES OF UPPER RESPIRATORY TRACTS | 1995 |
|
RU2085180C1 |
| METHOD FOR TREATING THE CASES OF EXTERNAL OTITIS | 2000 |
|
RU2163794C1 |
| METHOD FOR TREATING THE CASES OF PARATONSILLARY ABSCESS | 1994 |
|
RU2068715C1 |
| METHOD OF REVEALING NEUROSENSOR HEARING DISORDER AND ITS GROUP OF RISK | 1995 |
|
RU2084898C1 |
| METHOD FOR TREATING INFECTIOUS ALLERGIC RHINOSINUSOPATHY | 1996 |
|
RU2121359C1 |
| METHOD FOR TREATING PARATONSILLAR ABSCESS | 2001 |
|
RU2187258C1 |
